Leerink Partners report names Carterra a core enabler of the $7 B “Lab-in-the-Loop” antibody discovery marketJuly 27, 2026
Research Military’s testosterone screening program could lead to overtreatment and side effects, including impaired T productionBy Healthcare Propulsion StaffJuly 27, 20260 As recently as 2019, U.S. military health researchers had concerns about testosterone levels among the troops. Their worries were not…
